Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00048802 · ClinicalTrials.gov registry record · Phase 4
Treatment and Outcome of Early Onset Bipolar Disorder
A Phase 4 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00048802 is a Phase 4 study that has completed, run by Northwell Health. The registered enrollment target is 40 participants.
The verdict
NCT00048802, a Phase 4 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will compare the effectiveness in the maintenance of continuing adjunctive atypical antipsychotic medication compared to traditional mood stabilizer(s) alone in the maintenance treatment of adolescents with bipolar disorder.
Interventions
- DRUG Risperidone
- DRUG Lithium
- DRUG Olanzapine
- DRUG Quetiapine
- DRUG Divalproex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2002-08 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00048802
The ClinicalTrials.gov registry entry for NCT00048802 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Risperidone is the first listed.
NCT00048802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00048802 about?
NCT00048802 is a clinical study titled "Treatment and Outcome of Early Onset Bipolar Disorder". This study will compare the effectiveness in the maintenance of continuing adjunctive atypical antipsychotic medication compared to traditional mood stabilizer(s) alone in the maintenance treatment of adolescents with bipolar disorder.
What is the current status of trial NCT00048802?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2002-08. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00048802?
The interventions under investigation include: Risperidone (DRUG), Lithium (DRUG), Olanzapine (DRUG), Quetiapine (DRUG), Divalproex (DRUG).
Who is sponsoring clinical trial NCT00048802?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.